# Tocilizumab

## Actemra inj 162mg/0.9mL

| 藥物代碼 | IACTM |
| :--- | :--- |
| 適應症 | Moderate to severe active RA in adult patients, given alone or in combination w/ methotrexate \(MTX\) &/or other DMARDs. |
| 副作用 | Upper resp tract infections, cellulitis, oral herpes simplex, herpes zoster; abdominal pain, mouth ulceration, gastritis; rash, pruritus, urticaria; headache, dizziness; increased hepatic transaminases, increased wt; HTN; leucopenia, neutropenia; hypercholesterolaemia; peripheral oedema, hypersensitivity reaction, inj site reaction; cough, dyspnoea; conjunctivitis. |
| 禁忌 | Hypersensitivity to tocilizumab. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | Rheumatoid arthritis \(RA\): Note: Methotrexate or other nonbiologic disease-modifying antirheumatic drugs \(DMARDs\) may be continued for the treatment of rheumatoid arthritis. Tocilizumab should not be used in combination with biologic DMARDs. SubQ: =100 kg: 162 mg once every week. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - Probably Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | SC |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

